Burkina Faso’s ruling military government has suspended the activities of Target Malaria, an international research consortium that deploys genetically modified mosquitoes in the fight against malaria. The Ministry of Higher Education and Research announced the decision in a statement on Friday, confirming that all mosquito samples connected to the initiative will be destroyed following strict procedures.
Officials linked the suspension to broader efforts to curb the influence of foreign-backed NGOs operating in the country, a recurring theme under the current junta, which has prioritized national control over sensitive projects.
Origins of the Initiative
Target Malaria first launched in Burkina Faso in 2019 with a pilot release of genetically modified male mosquitoes in the village of Bana, a rural community of about 1,000 people in the country’s west. The male mosquitoes, which do not bite humans, were engineered to reduce the ability of female malaria-carrying mosquitoes to reproduce. The long-term objective was to suppress mosquito populations and, ultimately, reduce malaria transmission.
Malaria remains one of Africa’s most devastating health threats, claiming hundreds of thousands of lives annually. Target Malaria, which includes researchers and social scientists from Africa, Europe, and North America, has been testing innovative genetic technologies, including gene drive systems, as part of its efforts to combat the disease.
Since the first release, the project expanded to additional locations in Burkina Faso, with another small-scale release taking place only days before the government’s sudden suspension order.
Criticism and Opposition
The program has faced persistent criticism from activists and civil society groups in Burkina Faso and across Africa. Some campaigners accuse Target Malaria of worsening rather than alleviating the spread of malaria, while others warn that the technology carries unacceptable ecological risks.
Among the more vocal critics, French-Togolese activist Egountchi Behanzin described the suspension as a victory, framing the project as a foreign-driven experiment financed by powerful Western actors.
Opposition groups have also argued that eliminating a species—even a harmful one such as malaria-carrying mosquitoes—raises difficult ecological and ethical questions. They warn that disrupting mosquito populations could have unintended consequences for ecosystems, food chains, and biodiversity.
Ethical Concerns Raised
Activists in Burkina Faso have long questioned the safety and morality of the project. Ali Tapsoba, representing a coalition against the initiative, described the use of gene drive mosquitoes as “highly controversial” and unpredictable. Critics stress that the full impact of such organisms on human health and the environment remains uncertain and potentially irreversible.
For many, the controversy is not only about malaria control but also about who controls the process. The reliance on technology developed in European laboratories has fueled accusations of “scientific neo-colonialism,” with opponents arguing that foreign entities are imposing experimental solutions on African populations without fully accounting for local concerns.
Regulatory Approval and Compliance
Despite the backlash, Target Malaria had secured approvals from Burkina Faso’s main oversight bodies. The National Biosafety Agency, the National Environmental Assessment Agency, and the Health Research Ethics Committee had all authorized controlled releases. Communities in Houet Province also provided their consent.
In August 2025, a small-scale release of genetically modified male mosquitoes without gene drive traits was carried out under these regulatory frameworks. Target Malaria stressed that it has operated in Burkina Faso since 2012 in compliance with national laws and international biosafety standards, engaging with communities and government agencies throughout the process.
Civil Society Response
Still, local organizations remained skeptical. The Coalition for Monitoring Biotechnological Activities in Burkina Faso (CVAB) criticized the initiative as opaque, risky, and dominated by external influence. For many civil society leaders, the suspension reflects longstanding demands for greater transparency and locally driven solutions to health challenges.
The criticism also underscores a deeper distrust of international research projects, particularly those involving biotechnology, in regions where communities have limited influence over scientific decision-making.
Political Dimensions of the Decision
The halt to Target Malaria also fits into the broader political agenda of Burkina Faso’s military-led government. Since Captain Ibrahim Traoré took power in 2022, his administration has sought to limit foreign influence in domestic affairs, particularly in areas tied to health, security, and natural resources.
The government has framed Western-funded projects as undermining sovereignty, emphasizing instead the need for locally designed and safer alternatives. Projects linked to major international donors and philanthropists, such as Bill Gates, have faced increased scrutiny under this nationalist policy direction.
Scientific Potential vs. Public Concerns
Target Malaria’s use of gene drive technology has long been described as one of the most ambitious scientific approaches to malaria eradication. By spreading sterilizing genetic traits throughout mosquito populations, the method has the potential to significantly reduce or even eliminate malaria-carrying species.
While researchers view this as a breakthrough with the power to save millions of lives, critics warn that the ecological and ethical risks cannot be ignored. The uncertainty surrounding gene drive organisms raises fears about biodiversity loss and unintended long-term consequences.
The suspension represents a major setback for Target Malaria’s work in Burkina Faso and casts uncertainty on similar projects in other partner countries, including Mali, Uganda, and Ghana. The consortium has pledged to continue cooperating with Burkinabe authorities but faces an unclear future in the country.
